This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hallenbeck, J. M. Articles by Furlow, T. W. Search for Related Content PubMed PubMed Citation Articles by Hallenbeck, J. M. Articles by Furlow, T. W., Jr

Stroke, Vol 10, 629-637, Copyright © 1979 by American Heart Association

ARTICLES

Prostaglandin I2 and indomethacin prevent impairment of post-ischemic brain reperfusion in the dog

JM Hallenbeck and TW Furlow Jr

Twenty-seven heparinized dogs were exposed to 35 min of cerebrospinal fluid compression ischemia followed by 30 min of recirculation. The degree and distribution of post-ischemic reperfusion was then assessed by means of a 14C-antipyrine autoradiographic blood flow study. The animals were assigned to 5 groups by the administration of drugs as follows: 1) no additional drugs; 2) indomethacin 1.5 or 4 mg/kg prior to ischemia; 3) indomethacin 4 mg/kg 5 min after ischemia; 4) prostaglandin I2 (PGI2) infusion 30--180 ng/kg/min beginning 5 min after ischemia; and 5) indomethacin 4 mg/kg 5 min after ischemia plus PGI2 infusion 30--130 ng/kg/min beginning 5 min after ischemia. Animals receiving no additional drugs had relatively low post-ischemic blood flows with focal zones of greatly impaired reperfusion. Animals receiving either indomethacin or PGI2 after ischemia did not differ significantly from the no additional drug group. A significant enhancement of post-ischemic reperfusion occurred in animals receiving indomethacin prior to ischemia and those receiving the combination of indomethacin and PGI2 after ischemia. These observations implicate an imbalance in prostaglandin pathways at the blood-endothelial interface in the genesis of post-ischemic reflow impairment and suggest novel drug therapy for enhancing nutrient flow after ischemia.

This article has been cited by other articles:

				J. L. Wilterdink, B. Bendixen, H. P. Adams Jr, R. F. Woolson, W. R. Clarke, and M. D. Hansen Effect of Prior Aspirin Use on Stroke Severity in the Trial of Org 10172 in Acute Stroke Treatment (TOAST) Stroke, December 1, 2001; 32(12): 2836 - 2840. [Abstract] [Full Text] [PDF]

				H. Tong, E. Richards, and C. E. Wood Prostaglandin Endoperoxide Synthase-2 Abundance Is Increased in Brain Tissues of Late-Gestation Fetal Sheep in Response to Cerebral Hypoperfusion Reproductive Sciences, May 1, 1999; 6(3): 127 - 135. [Abstract] [PDF]

				M. A. Sloan Thrombolysis and Stroke: Past and Future Arch Neurol, July 1, 1987; 44(7): 748 - 768. [Abstract] [PDF]

				B. C. White, J. G. Wiegenstein, and C. D. Winegar Brain Ischemic Anoxia: Mechanisms of Injury JAMA, March 23, 1984; 251(12): 1586 - 1590. [Abstract] [PDF]